Skip to main content
Fig. 3 | World Journal of Surgical Oncology

Fig. 3

From: Afatinib combined with anlotinib in the treatment of lung adenocarcinoma patient with novel HER2 mutation: a case report and review of the literature

Fig. 3

Brain magnetic resonance imaging (MRI) after treatment with afatinib and anlotinib. A Before any treatment. B Before afatinib treatment. C Brain MRI showing partial response after 1 month of afatinib and anlotinib. D Brain MRI showing stable disease after 5 months of afatinib and anlotinib. E Brain MRI showing progressive disease after 10 months of afatinib and anlotinib

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us